Two major autoantibody clusters in systemic lupus erythematosus

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Ching, Kathryn H ^a,d   Burbelo, Peter D ^a   Tipton, Christopher ^b   Wei, Chungwen ^b   Petri, Michelle ^c   Sanz, Ignacio ^b   Iadarola, Michael J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN; AQUAPORIN 4; AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE 65; INTERFERON; LA ANTIGEN; OMEGA INTERFERON; RIBONUCLEOPROTEIN ANTIBODY; RNP 70K ANTIGEN; RO52 ANTIGEN; RO60 ANTIGEN; SM D3 ANTIGEN; UNCLASSIFIED DRUG; AUTOANTIGEN; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MUSCULOSKELETAL DISEASE; NUCLEOTIDE SEQUENCE; PILOT STUDY; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; SKIN DISEASE; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; BLOOD; CLUSTER ANALYSIS; ETHNOLOGY; IMMUNOLOGY; METABOLISM; NERVE CELL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; CLUSTER ANALYSIS; COHORT STUDIES; HUMANS; IMMUNOPRECIPITATION; INTERFERONS; LUCIFERASES, RENILLA; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEURONS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84857420334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032001     Document Type: Article

References (37)

1. Rahman A, Isenberg DA, (2008) Systemic lupus erythematosus. N Engl J Med 358: 929-939.
2. Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, et al. (2011) Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum 63: 1044-1053.
3. Lockshin MD, (2006) Sex differences in autoimmune disease. Lupus 15: 753-756.
4. Powell JJ, Van de Water J, Gershwin ME, (1999) Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 107 (Suppl 5): 667-672.
5. Sestak AL, Furnrohr BG, Harley JB, Merrill JT, Namjou B, (2011) The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis 70 (Suppl 1): i37-43.
6. Chung SA, Taylor KE, Graham RR, Nititham J, Lee AT, et al. (2011) Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 7: e1001323.
7. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204-210.
8. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y, (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34: 501-537.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277.
10. Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, et al. (2004) Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 63: 1155-1158.
11. To CH, Petri M, (2005) Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 52: 4003-4010.
12. Malik S, Bruner GR, Williams-Weese C, Feo L, Scofield RH, et al. (2007) Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients. Lupus 16: 863-866.
13. Somers E, Magder LS, Petri M, (2002) Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 29: 2531-2536.
14. Burbelo PD, Ching KH, Bren KE, Iadarola MJ, (2011) Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems. Expert Rev Proteomics 8: 309-316.
15. Burbelo PD, Ching KH, Han BL, Bush ER, Reeves WH, et al. (2010) Extraordinary antigenicity of the human Ro52 autoantigen. Am J Transl Res 2: 145-155.
16. Burbelo PD, Leahy HP, Issa AT, Groot S, Baraniuk JN, et al. (2009) Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome. Autoimmunity 42: 515-524.
17. Burbelo PD, Goldman R, Mattson TL, (2005) A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol 5: 22.
18. Burbelo PD, Ching KH, Klimavicz CM, Iadarola MJ, (2009) Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp.
19. Liu E, Eisenbarth GS, (2007) Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol 125: 120-126.
20. Burbelo PD, Browne SK, Sampaio EP, Giaccone G, Zaman R, et al. (2010) Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia. Blood 116: 4848-4858.
21. Burbelo PD, Seam N, Groot S, Ching KH, Han BL, et al. (2010) Rapid induction of autoantibodies during ARDS and septic shock. J Transl Med 8: 97.
22. Burbelo PD, Leahy HP, Groot S, Bishop LR, Miley W, et al. (2009) Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection. Clin Vaccine Immunol 16: 621-627.
23. Burbelo PD, Leahy HP, Iadarola MJ, Nutman TB, (2009) A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis 3: e438.
24. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533.
25. Jurencak R, Fritzler M, Tyrrell P, Hiraki L, Benseler S, et al. (2009) Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 36: 416-421.
26. Fox RI, (2005) Sjogren's syndrome. Lancet 366: 321-331.
27. Isenberg DA, Garton M, Reichlin MW, Reichlin M, (1997) Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Br J Rheumatol 36: 229-233.
28. Tang X, Huang Y, Deng W, Tang L, Weng W, et al. (2010) Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: a retrospective review of 917 patients in South China. Medicine (Baltimore) 89: 62-67.
29. Deocharan B, Qing X, Lichauco J, Putterman C, (2002) Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 168: 3072-3078.
30. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100: 2610-2615.
31. Morimoto AM, Flesher DT, Yang J, Wolslegel K, Wang X, et al. (2011) Association of endogenous anti-interferon-alpha autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum.
32. Nikpour M, Dempsey AA, Urowitz MB, Gladman DD, Barnes DA, (2008) Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis 67: 1069-1075.
33. Slavikova M, Schmeisser H, Kontsekova E, Mateicka F, Borecky L, et al. (2003) Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia. J Interferon Cytokine Res 23: 143-147.
34. von Wussow P, Jakschies D, Hartung K, Deicher H, (1988) Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 8: 225-230.
35. Meager A, Visvalingam K, Peterson P, Moll K, Murumagi A, et al. (2006) Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3: e289.
36. Merrill JT, Wallace DJ, Petri M, Kirou KA, Yao Y, et al. (2011) Safety profile and clinical activity of sifalimumab, a fully human anti-interferon alpha monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Ann Rheum Dis 70: 1905-1913.
37. Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, et al. (2009) Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 60: 1785-1796.